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Abstract 
The recent acknowledgment of the paracrine role of perivascular adipose tis-
sue (PVAT) in vascular modulation has been supported by many studies in-
vestigating major arteries in several animal models and humans. The influ-
ence of PVAT on the functional activity of the vascular bed has been a matter 
of debate, whether it is an anticontractile effect with protective roles or a 
pro-contractile effect, investigations are underway to address this obscuri-
ty. In this investigation, we have studied the effects of vasoconstrictors, pheny-
lephrine and noradrenaline, and vasorelaxants, carbachol and s-nitroso-n- 
acetylpenicillamine (SNAP), on subclavian and iliac rings with and without 
PVAT attached; and concentration-response curves were constructed accor-
dingly. Levels of nitric oxide (NO) generated due to activation of the enzyme 
adenosine monophosphate-activated protein kinase (AMPK) by 5-Aminoimi- 
dazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) were measured in sub- 
clavian and iliac PVAT conditioned media. Additionally, Haematoxylin and 
Eosin staining was performed to analyze and compare the histological cha-
racteristics of both arteries. Subclavian and iliac rings with PVAT attached 
showed stronger contraction to phenylephrine and noradrenaline than that of 
rings without PVAT attached. At the same time, relaxation tests reported 
lower relaxation percentages in subclavian and iliac rings with PVAT attached 
compared to rings without PVAT attached in response to carbachol and 
SNAP. PVAT treated with AICAR generated higher levels of NO compared to 
levels of untreated PVAT. Conclusions drawn were the pro-contractile effects 
demonstrated by the PVAT especially in high concentrations of drugs used. 
In addition, histology analysis revealed characteristics of white adipose tissue 
in both PVATs. 
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1. Introduction 
The perivascular adipose tissue (PVAT) is becoming an important part of the 
cardiovascular system that plays a significant role in vascular modulation. It 
possesses paracrine signaling that influences the vasculature, and therefore the 
vascular function. Described as “The sixth man of the cardiovascular system” by 
Cheng et al. [1], the PVAT is not merely a mechanical support as believed in the 
past, but is an endocrine organ that regulates and modifies the vascular tone 
through communication with incoming neuronal signals, interaction with in-
flammatory mediators, and as a secreting entity that causes contraction/relaxa- 
tion of the vascular wall. These capabilities make it possible that PVAT will 
emerge as a potential therapeutic target in controlling vascular responses to dif-
ferent constricting and relaxing drugs, in addition to its possible participation in 
the underlying causes of atherosclerosis, diabetes mellitus, and cardiovascular 
diseases. Figure 1 illustrates the anatomical position of PVAT in an artery. 
Typically, the adipose tissue is composed of three types of adipocytes; white, 
brown, and beige depending on its region [2]. White adipose tissue (WAT) is 
characterized by its white and large adipocytes that function typically as energy 
storage. Brown adipose tissue (BAT) is termed so due to the high number of 
mitochondria that makes it recognizable by its metabolic activity and smaller 
adipocyte size. The mitochondrial content gives the characteristic brown color of 
the BAT that is heavily innervated to respond to sympathetic impulses to gener-
ate heat and energy [3]. Although it is less well innervated than BAT, WAT is 
distributed throughout different tissue depots that store fatty acid molecules as 
triglycerides and these surround multiple organs to form visceral fat and distribute 
 
 
Figure 1. The PVAT is positioned in the external layer of the artery (Tunica externa, also known as Tunica adventitia), where it 
retains the physical function of protecting the artery in addition to its paracrine properties that influence the arterial tone. The 
perivascular nerve supply is attached to the PVAT and the rest of the artery allowing interpretation of neuronal impulses by 
PVAT, VSMCs and endothelium for an action to be concluded [14]. 
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in subcutaneous areas. The low mitochondrial content is accredited to its energy 
saving capacity and mechanical support for the body. Moreover, WAT contains 
beige adipocytes that are also called brown-like adipocytes, which differ from 
BAT in that they contain lower expression of uncoupling protein 1 (UCP1). Also 
called Thermogenin, UCP1 is most abundant in the mitochondria of the BAT. It 
contributes to nonshivering thermogenesis, a process by which the BAT gene-
rates heat [2]. 
Interestingly, the PVAT is composed of both WAT and BAT depending on its 
location in the body. Studies have shown that PVAT phenotype is related to its 
anatomical position in the body; however, in pathological conditions, the in-
creased levels of Angiotensin II and pro-atherosclerotic factors leads to dediffe-
rentiation of adipocytes in PVAT [3]. In addition, recent studies demonstrated 
that mice exposed to chronic cold or continuous adrenergic stimulation can lead 
to conversion of WAT to brown or beige in a process called “Beiging of WAT”, 
which favors breaking down, rather than storing, triglycerides in lipid droplets 
[2] [4]. This is supported by the functional similarities such as thermogenesis 
and energy production seen in both brown PVAT and BAT in cold temperatures 
[5]. Generally, the PVAT in the iliac vessel displays an equal amount of brown 
and white adipocytes, while PVAT surrounding the subclavian artery appears to 
be brown, which are the two vessels adopted in this investigation using rabbits 
[4] [6]. 
With differences in adipocyte color and expression level of UCP1 in PVAT, its 
effect on arterial vasculature remain to be the topic of recent studies. Its activity 
as an endocrine and paracrine organ has been established as it produces many 
substances that influence the underlying vascular smooth muscle cells (VSMCs) 
in major arteries. PVAT, along with the endothelium, are the pathways that 
modulate the vascular tone, which can have detrimental effects on vascular effi-
ciency in pathological conditions. The adipose tissue within the PVAT secretes 
biologically active molecules that can be classified into adipokines such as adi-
ponectin, leptin, resistin, and visfatin; cytokines such as tumor necrosis factor-α 
(TNF-α) and interleukins; and nitric oxide (NO) and hydrogen sulfide (H2S), 
which both identify as gaseous molecules that play critical role in initiating re-
laxation in the VSMCs. PVAT is a source of reactive oxygen species like supe-
roxide and hydrogen peroxide (H2O2), which play pivotal roles in contraction 
and relaxation of VSMCs respectively [1] [3] [7]. 
Categorically, some of the released molecules can have either contractile or 
anticontractile effects. Adiponectin, H2S, and angiotensin 1 - 7 have been sug-
gested to be relaxing factors that activate calcium-dependent (KCa) potassium 
channels in VSMCs, which causes relaxation [5]. Typically, there are two me-
chanisms through which the PVAT exerts its anti-contractile effects. The endo-
thelium-dependent relaxation, which activates endothelial nitric oxide synthase 
(eNOS) to synthesize NO that ultimately causes opening of KCa channels by sti-
mulating soluble guanylyl cyclase (sGC) to produce cyclic guanosine monophos-
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phate (cGMP), and the endothelium-independent relaxation that involves the 
production of H2O2, which either activates eNOS or directly causes relaxation 
through hyperpolarization of KCa channels [5] [8] [9]. Either way, the NO and 
H2O2 are critical in transforming relaxation signals to actual vasodilation, but the 
molecular process that leads to their activation by adipokines and other PVAT- 
derived substances remain elusive. 
One proposed pathway which acquired the attention of many of the studies 
concerned with vascular molecular interactions is the activation of adenosine mo-
nophosphate-activated protein kinase (AMPK) by different PVAT-derived relax-
ing factors like adiponectin [4]. In a recent study, it was hypothesized that AMPK 
activates eNOS by phosphorylation. Aortic PVAT-containing rings from AMPK 
knock-out (KO) mice were compared with the wild type (WT) in terms of re-
sponse to contractile and relaxant agents. In the KO mice, the contraction re-
sponse to U46619 was significantly higher than in WT mice; moreover, rings 
from KO mice had reduced relaxation in response to cromakalim; therefore the 
reduced anti-contractile effects of PVAT are attributed to the diminished con-
tent of AMPK, which in WT mice is activated by phosphorylation due to adi-
ponectin secretion by PVAT [1] [8]. Because of the apparent importance of 
AMPK in our investigation, we have studied the effect of 5-Aminoimidazole- 
4-carboxamide-1-β-D-ribofuranoside (AICAR), an AMPK activator, on the pro-
duction of NO from PVAT taken from subclavian and iliac arteries of rabbits. 
PVAT can also produce molecules that possess contractile effects such as an-
giotensin II and superoxide [8]. In rat mesenteric artery, the release of angioten-
sin II by the PVAT plays a critical role in promoting electrical field stimulation 
(EFS)-mediated contraction, which suggests that physiological neuronal stimula-
tion enhances the constricting effect of angiotensin II. Moreover, treatment with 
an angiotensin I-converting enzyme inhibitor (ACEI) enalaprilat and angiotensin 
II type I receptor blocker (ARB) candesartan diminished the EFS-mediated con-
traction in arteries with PVAT attached, while arteries with removed PVAT were 
unaffected proving that the PVAT is the actual source of angiotensin II [10]. 
Takemori et al. [11] also showed that blood vessels of genetically modified lipoa-
trophic mice that suffer from loss of adipose tissue have contractile behavior that 
subsequently leads to development of hypertension, and that this pro-contractility 
is attributed to increased expression of vascular angiotensin II type I receptors. 
This study also suggests that PVAT is a contributing factor in maintaining normal 
levels of angiotensin II; as the vascular demand, portrayed by number of receptors 
expressed, for angiotensin II has increased due to PVAT absence. 
In small arteries taken from visceral fat of obese patients, the contractile effect 
of PVAT was evident in the increased production of TNF-α, which reduced NO 
bioavailability due to the production of superoxide by activating nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase and inducible NOS (iNOS), 
and inhibition of eNOS [12]. Suggesting that obesity-induced inflammatory ac-
tivity supports pro-contractile effects of PVAT and a further study of how this is 
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involved in cardiovascular complications is warranted [13]. Additionally, superox-
ide can also be produced by the NADPH oxidase-stimulating activity of angioten-
sin II, which then induces the activation of tyrosine kinase and subsequent activa-
tion of MAPK/ERK1/2 pathway; thereby emphasizing the involvement of the re-
nin-angiotensin system (RAS) in influencing the paracrine function of PVAT [10]. 
In pathological conditions such as obesity, atherosclerosis, cardiovascular and 
metabolic diseases, PVAT secretion balance is disturbed. For example, its con-
tent of immune cells and chemokines is upregulated, which creates an inflam-
matory state that increases proliferation and activation of macrophages and T- 
lymphocytes, which in turn reduces the release and anti-inflammatory and dila-
tory effects of protective adipokines, and favors the release of contractile agents 
and pro-inflammatory adipokines such as TNF-α and interleukin-6 [13]. Con-
sequently, dysfunctional PVAT can have a detrimental impact on the production 
and activation of NO. NO content in PVAT is of interest and has been measured 
in the current research reported here, and it may play a critical role in develop-
ment of pathophysiological conditions. 
The consideration of PVAT as a therapeutic target has been growing recently 
with studies showing evident paracrine roles and unknown participation in many 
physiological pathways that are yet to be established. One is the autonomic in-
nervation of PVAT, which is not fully understood and which may play an im-
portant role in defining the secretion profile of the PVAT that influences vascu-
lar function; secondly, the regional differences in PVAT adipocytes, whether their 
color or level of differentiation, may have effects on secretion capacity of certain 
adipokines that in turn affects the total function and participation of PVAT in 
vascular modulation. With the gained knowledge of signaling pathways and 
the variant adipocyte phenotypes in different regions of the body, PVAT-derived 
adipokines can be considered as targets and biomarkers in therapeutic and di-
agnostic measures of cardiovascular and metabolic disorders. 
The aim of this investigation is to study the effects of phenylephrine and no-
radrenaline as constrictors, and carbachol and S-Nitroso-N-Acetylpenicillamine 
(SNAP) as relaxers in rings with and without PVAT taken from subclavian and 
iliac arteries of rabbits using wire myography. Moreover, an NO analyzer (NOA) 
was used to measure NO concentrations in PVAT conditioned media treated 
with AICAR compared to untreated media; as AMPK is suspected to mediate 
anticontractile effects of PVAT, NO concentrations in treated media are expected 
to rise as opposed to untreated media. In addition, visualizing and identifying 
adipose tissue in PVAT to understand the association of increased UCP-1 ex-
pression in brown PVAT to its adipokine secretion profile that influence the 
vascular tone. 
2. Methodology 
2.1. Animal Model and Artery Preparation 
Rabbits used in this study were 18-week-old New Zealand White males. They 
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were provided by Envigo and maintained at ambient temperatures. Animals 
were euthanized using 1 ml of 200 mg/ml phenobarbital (IV) injection into the 
marginal ear vein. Subclavian and iliac arteries were dissected and kept in cold 
oxygenated (95%: O2: 5% CO2) Krebs solution, also known as Physiological Salt 
Solution (PSS), which is prepared using the composition: 119 mM NaCl, 4.7 mM 
KCl, 1.2 mM MgSO4, 24.9 mM NaHCO3, 1.2 mM KH2PO4, 11.1 mM Glucose 
and 2.5 mM CaCl2, and stored at 2˚C - 8˚C for up to a week. Arteries were then 
isolated from surrounding tissue and sectioned into 2 mm long rings with and 
without PVAT attached. 
2.2. Large Vessel Wire Myography 
The rings were mounted on a 4-channel DMT wire myograph. Each channel is 
composed of a temperature-regulated bath with suction mechanism, gas supply 
and pair of pins. One pin is attached to a micrometer to allow control of vessel 
circumference, and the other is attached to a force transducer that measures the 
tension caused by the vessel in response to certain compounds. The baths were 
filled with 5 ml of cold Krebs solution with the gas valve opened to sustain 
oxygen supply for the vessel. Rings were then mounted on the pins carefully 
under the microscope to ensure the endothelium remains undamaged during 
the process. Vessels were then stretched to 9.8 Millinewtons (mN), which is 
equivalent to 1 gram of force, followed by turning the heating system on with 
temperature set to 37.5˚C and washing baths with warm Krebs solution; then 
vessels were allowed to stabilize for at least 30 minutes. After stabilization, trans- 
ducers were zeroed to set 9.8 mN as the baseline. Figure 2 shows two mounted 
rings. 
Baths were emptied and filled with 5 ml of warm 62.5 mM of KPSS, which is a 
high potassium-containing PSS, of the composition: 1.2 mM MgSO4, 62.5 mM  
 
 
Figure 2. (a) shows a ring with no PVAT attached mounted on the pins of the 
myograph and stretched to 9.8 mN, while (b) shows a ring with intact PVAT 
in a similar position. 
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KCl, 24.9 mM NaHCO3, 1.2 mM KH2PO4, 2.5 mM CaCl2 and 11.1 mM Glucose, 
to stimulate the vessels to “wake up” after a period of inactivity. Solution was left 
for 5 minutes, then washed with PSS three times to allow steady return to base-
line. Subsequent addition of KPSS stimulates vessels to generate maximum con-
traction in response to extreme depolarization of VSMCs by the high amount of 
potassium followed by three-time washing with PSS to return the vessel to base-
line for addition of vasoconstrictors. 
2.3. Endothelial Check and Cumulative Dosing 
Testing the endothelial function and integrity was conducted using a single dose 
of acetylcholine to give concentration of 1 × 10−6 M in the organ baths after the 
arteries were pre-contracted using a single dose (concentration ranging from 1 × 
10−6 to 1 × 10−5 M) of either phenylephrine or noradrenaline depending on the 
ring’s responsiveness to the dosage. A minimum relaxation of 50% or more was 
considered adequate for the endothelium to be deemed functional; as cholinergic 
receptors are situated on the surface of the endothelial cell that activate relaxa-
tion cascade through NO. Thereafter, baths were washed with PSS three times 
and left to stabilize to baseline. 
Stable rings, with and without PVAT attached, were tested with cumulative 
doses of vasoconstrictor and relaxant agents. Average response to phenylephrine 
and noradrenaline as contracting agents was calculated and compared. Doses were 
added at five-minute intervals to yield concentrations starting from 1 × 10−9 M 
progressing to 3 × 10−5 M. Concentration-response curves were constructed to 
identify PVAT influence on vessel contractility. 
On the other hand, pre-contracted rings responses to SNAP and carbachol as 
relaxants were measured as percentage relaxation. Rings were pre-contracted 
with various submaximal doses of phenylephrine to generate sustained and 
submaximal contraction as baseline for relaxation data. Addition of relaxant was 
at five-minute intervals and concentrations ranged from 1 × 10−9 M to 1 × 10−5 
M. 
2.4. PVAT Conditioned Media Preparation and Nitric Oxide  
Quantification 
Measurement of PVAT-derived nitric oxide concentrations in conditioned me-
dia was conducted under the influence of AICAR, which is an AMPK activator, 
and compared with control media to examine the anti-contractile effect of AMPK 
and its involvement in NO production. PVAT was isolated from both arteries, 
weighed and divided equally in Eppendorf tubes with cold PSS solution. Tubes 
were then placed in distilled water baths set to 37˚C with gas supply to warm up 
for 10 minutes before addition of AICAR. Dose was added to yield a concentra-
tion of 1 × 10−3 M and allowed to incubate for 30 minutes before removal of 
PVAT for snap freezing using liquid nitrogen. Thereafter, 100 μl of the media 
was extracted and diluted with methanol at 1:5 and centrifuged at 17 × g for 20 
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minutes at 4˚C temperature, while the remaining 900 μl of the media was stored 
at −80˚C. Supernatant was collected to eliminate potential contaminant peptides 
for NO quantification as peptides lead to formation of foam in the purge vessel 
of the NOA, which affects the measurements of NO concentrations. 
Measurement of NO concentrations was performed using Sievers 280 NOA, 
which measures NO in the chemiluminescence reaction cell. The NO secreted 
from the PVAT is oxidized in the conditioned media to produce nitrite; for this 
reason, the NOA is connected to a radical purger that contains a reducing agent 
(1% wt/vol of NaI in acetic acid) and a nitrogen gas supply to convert nitrite 
back to NO for measurement by the NOA. After calibration of NOA using a 
range of concentrations of sodium nitrite (NaNO2), the supernatant was injected 
into the purge vessel in duplicates and their average was taken as the final NO 
concentration in the supernatant. Lastly, blank media was prepared using only 
the PSS solution to eliminate potential nitrite contamination within the media. 
The final concentration was adjusted for the blank, the dilution with methanol at 
1:5 and the PVAT weight to calculate the amount of NO secreted by one milli-
gram of PVAT in one hour. 
2.5. Histology 
Visualization and identification of the type of fat within the PVAT of subclavian 
and iliac arteries was performed starting with the incubation of isolated PVAT 
specimens and rings with intact PVAT into 10% acetic zinc formalin overnight. 
Tissues were then processed using a Leica Benchtop Tissue Processor through 
the program shown in Table 1 for appropriate dehydration before embedding in 
paraffin wax. Thermo Shandon Histocentre 3 was used for the embedding of 
tissues in molten paraffin wax that subsequently solidified and blocks were 
stored in the freezer overnight. Thereafter, blocks of wax containing the tissue  
were sectioned into 7 μm slices using Thermo Shandon Finesse 325 Manual Mi-
crotome and transferred onto slides for staining. 
 
Table 1. Tissue processor program sequence of solutions and its corresponding times of 
incubation. 
Solution Time of Incubation 
70% Ethanol 2 Hours 
90% Ethanol 2 Hours 
100% Ethanol contaning 2% Celloidin 1 2 Hours 
100% Ethanol contaning 2% Celloidin 2 2 Hours 
100% Ethanol contaning 2% Celloidin 3 2 Hours 
Amyl Acetate 1 2 Hours 
Amyl Acetate 2 2 Hours 
Amyl Acetate 3 2 Hours 
Molten wax 1 4 Hours 
Molten wax 2 4 Hours 
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In order to stain the tissue, it must go through a process of rehydration. There-
fore, slides were placed into Histoclear solution (a xylene substitute) for 10 mi-
nutes to de-wax the tissues before the rehydration has begun. The slides were 
then processed through different concentrations of alcohol; 30 seconds in 100% 
ethanol, 30 seconds in 90% ethanol and 1 minute in 70% ethanol; then the rehy-
dration process was completed with washing for 1 minute in water. Thereafter, 
staining of tissue took place by submerging slides into Haematoxylin (Mayer’s) 
stain for 8 minutes before washing with water for 1 minute. Slides were then 
submerged into Scott’s solution for 1 minute to transform the red color of Hae-
matoxylin to blue that stains the nucleus. Finally, two 1-minute washes with wa-
ter took place before and after placing slides into 1% Eosin stain for 3 minutes. A 
further dehydration process was performed before mounting coverslips onto 
slides with DPX (histological mounting medium). Dehydration started with plac-
ing slides for 30 seconds in 70% ethanol to rapidly differentiate Eosin, 1 minute 
in 90% ethanol to differentiate Eosin slowly, 4 minutes in 100% ethanol and fi-
nally cleared in Histoclear solution for 10 minutes. Visualization and photogra- 
phing of specimens were possible after allowing the DPX to dry overnight. 
2.6. Statistical Analysis 
Constriction and relaxation data were analyzed using two-way ANOVA test for 
the significance of the difference in response between rings with PVAT and rings 
without PVAT, while a student’s paired t-test was performed for comparing NO 
secretion profile of PVAT before and after AICAR treatment. Resulting p-values 
are shown in each diagram and the cutoff for significance is the p-value of 0.05, 
where values less than 0.05 are considered significant. 
3. Results 
3.1. Constriction Data 
Subclavian and iliac rings with and without PVAT attached were tested with two 
vasoconstrictors, phenylephrine and noradrenaline; and responses to a range of 
concentrations were detected on the myograph in mN and used to construct 
concentration-response curves, in Figure 3, to demonstrate the effect of PVAT 
on constriction response. 
Similar response curves can be seen in Figure 3(a) demonstrating that sub-
clavian rings with and without PVAT attached contracted to the same extent to 
phenylephrine. The marginal differences in responses were in compliance with 
the two-way ANOVA test result of insignificance. Variability in responses seem 
to increase with the growing concentration of phenylephrine. On the other hand, 
the apparent difference between responses of rings with PVAT and of rings 
without PVAT to noradrenaline in Figure 3(b) was significant. The variability 
in responses was less in rings without PVAT than in rings with PVAT. Stronger 
contractions were produced by the subclavian rings with PVAT in response to 
noradrenaline compared to phenylephrine. The effects of phenylephrine on 
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Figure 3. (a) and (b) show concentration-response curves of subclavian rings with and without PVAT attached (n = 6 each) tested 
with cumulative dosing of phenylephrine and norepinephrine respectively. (c) and (d) show concentration-response curves of iliac 
rings with and without PVAT attached (n = 6 each) tested with cumulative dosing of phenylephrine and norepinephrine respec-
tively. The asterisk (*) identifies the significant difference. 
 
subclavian rings appeared to be consistent with the effects on iliac rings. Iliac 
rings with and without PVAT appeared to have similar contraction responses to 
low and intermediate concentrations of phenylephrine, but rings with PVAT 
showed a stronger contraction to high concentrations (8e−6, 1e−5 and 3e−5) as 
displayed in Figure 3(c); nevertheless, the difference in response was deemed 
insignificant by the ANOVA test. The variability followed the same pattern as in 
the subclavian rings but maintained the level of stability in higher concentra-
tions. Responses of iliac rings to noradrenaline seem to increase throughout the 
range of concentrations, with the rings with PVAT showing a stronger contrac-
tion as seen in Figure 3(d); however, the difference was statistically insignifi-
cant. 
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3.2. Relaxation Data 
Pre-contracted subclavian and iliac rings were treated with carbachol and SNAP 
to examine the effects of intact PVAT on endothelium-dependent and endothe-
lium-independent relaxation respectively. Relaxation percentages in relation to 
relaxant concentrations have been used to construct concentration-response 
curves as shown in Figure 4. 
Relaxation percentages of the subclavian rings treated with SNAP were higher 
in rings without PVAT as presented in Figure 4(b); but compared to rings with 
PVAT, the difference was statistically insignificant. However, the difference in 
relaxation percentages between rings with PVAT and rings without PVAT in the 
iliac artery was shown to be significant, as higher relaxation percentages were 
seen in rings without PVAT in Figure 4(d). Effects of carbachol on both sub-
clavian and iliac arteries also produced higher relaxation percentages in rings 
 
 
Figure 4. (a) and (b) show concentration-response curves of pre-contracted subclavian rings with and without PVAT attached 
(n = 6 each) tested with cumulative dosing of carbachol and SNAP respectively. (c) and (d) show concentration-response 
curves of pre-contracted iliac rings with and without PVAT attached (n = 6 each) tested with cumulative dosing of carbachol 
and SNAP respectively. The asterisks (*) identify significant differences, greater significance is identified with more than one 
asterisk. 
A. Abdulrazzaq, S. Kennedy 
 
 
DOI: 10.4236/pp.2020.1112027 342 Pharmacology & Pharmacy 
 
without PVAT as seen in Figure 4(a) and Figure 4(c) respectively, but analysis 
of both differences in comparison to rings with PVAT were insignificant. Varia-
bility in responses of iliac rings with and without PVAT seem to overlap in al-
most all concentrations of carbachol. This data together with the constriction 
data provided above suggest that arteries with PVAT seem to have a tendency 
towards vasocontraction. 
3.3. Nitric Oxide Measurements 
Measurement of NO concentration by NOA was performed on eight samples of 
PVAT from each artery. The average of two concentration readings of each 
sample media was calculated and adjusted with subtraction of the average of two 
blank concentrations, in addition to multiplication by five to account for the 
previous dilution with methanol, and division by the weight of PVAT in media 
to obtain the NO secretion rate for every milligram of PVAT. Figure 5(a) and 
Figure 5(b) illustrate NO measurements for subclavian and iliac PVATs respec-
tively. 
Both subclavian and iliac PVAT demonstrated a higher secretion rate when 
treated with the AMPK-activating compound AICAR; however, secretion rates 
were insignificant in the case of iliac PVAT. At the same time, the difference in 
mean secretion rate between treated and untreated subclavian PVAT can be seen 
clearly in Figure 5(a), which was considered significant by the paired t-test. 
Contrary to subclavian PVAT, although the treated iliac PVAT produced an in-
creased levels of NO per hour compared to the untreated PVAT as seen in Fig-
ure 5(b) below, the difference was insignificant. 
 
 
Figure 5. (a) Shows bar graph of the mean NO secretion rate for every milli-
gram of subclavian PVAT treated and untreated with a concentration of 1e−3 
M of AICAR (n = 8 each). (b) Shows the same data for iliac PVAT. The aste-
risk (*) identifies the significant difference. 
A. Abdulrazzaq, S. Kennedy 
 
 
DOI: 10.4236/pp.2020.1112027 343 Pharmacology & Pharmacy 
 
3.4. Histology Analysis 
After the inspection of stained sections of subclavian and iliac rings using the 
microscope, structural layers of the artery were identified and are shown in Fig-
ure 6 below. 
Histological sections in Figure 6 shows the primary structural components of 
the arterial vessel. The red interior layer of the artery, seen in the far right of 
both (a) and (b), represents the endothelial cells with its nuclei recognized by the 
dark blue dots. Followed by a layer of smooth muscle cells that is clearly distin-
guished from its adjacent adventitia (Tunica externa) pink-colored layer. The 
outermost layer is the PVAT, where adipocytes and their nuclei look identical in 
both subclavian and iliac sections. The characteristic large lipid droplet of the 
adipocyte shown in (a) and (b) resemble lipid droplets of a WAT, suggesting 
that the subclavian and iliac PVAT carry properties of a white PVAT. 
4. Discussion 
The hallmark finding of this investigation is the marginal pro-contractile effects 
of subclavian and iliac PVAT seen in both functional tests, contraction and re-
laxation, performed using myography. Although mostly insignificant; difference 
in responses to both functional tests in both arteries are manifestations of many 
underlying factors that are related to the type, region and secretory profile of the 
PVAT; which might affect the degree of vascular response to a certain treatment 
under hypertensive conditions. 
Activation of the alpha-adrenergic receptors located on the smooth muscle 
cells by phenylephrine and noradrenaline leads to depolarization of myocytes 
and ultimately contraction of the muscular bundle that leads to narrowing of the 
vascular wall [15]. There are many PVAT-derived molecules that may explain 
the increased contraction in rings with PVAT; however, leptin is a prominent  
 
 
Figure 6. (a) Displays a stained section of the subclavian artery with its distinctive arterial layers, while (b) Displays the same for 
the iliac artery. PVAT, perivascular adipose tissue; Adv., adventitia; VSMCs, vascular smooth muscle cells; End, endothelium. 
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molecule that has been suggested to exhibit contractile characteristics in many 
studies related to vascular modulation. In one study performed on rat portal 
vein (RPV), investigators found that stretching of RPV resulted in significant 
upregulation of leptin levels exceeding 100-fold, and a further increase in ex-
pression levels of leptin receptors by 10-fold. The increased activity of leptin that 
led to vascular smooth muscle proliferation, evident by the increased weight of 
the tissue, was associated with increased activity of angiotensin II and endothe-
lin-1 (ET-1) systems [16]. Moreover, endothelin-1 is a potent vasoconstrictor 
produced by the endothelium as a counterpart to NO. ET-1 mediates cell proli-
feration by activating ETA and ETB receptors and under pathological circums-
tances that lead to endothelial dysfunction, such as obesity, ET-1 secretion is 
highly augmented [17]. Another study has witnessed leptin-induced arterial 
hypertrophy by a different pathway. The investigation involved the use of swine 
coronary arteries exposed to obese concentrations of leptin. Results demonstrated 
that acute (30 minutes) and chronic (3 days) exposure to obese concentrations of 
leptin potentiated smooth muscle proliferation and increased contraction, which 
with inhibition of Rho kinase signaling were diminished. The use of fasudil, an 
Rho kinase inhibitor, produced a significant reduction in the KCl-induced con-
tractions of arteries treated with leptin relative to untreated arteries. The authors 
suggest that treatment with obese concentrations of leptin potentiated depolari-
zation-induced contraction of coronary arteries; however, whether the activation 
of RhoA/Rho kinase is related to vascular activity of leptin is still unclear [18]. 
Another highly active vasoconstrictor that may account for the increased vas-
cular contraction is angiotensin II. It is clear that the RAS is one of the most 
important regulators of the cardiovascular system and is becoming a substantial 
part of the endocrine function of the adipose tissue. Adipose tissue-derived RAS 
members angiotensin II and angiotensin 1 - 7 maintains physiological function 
of the vascular network and hence the cardiac function [19]. Many studies de-
scribe the alteration in adipose tissue secretion profile of RAS members in pa-
thological conditions such as obesity and hypertension. In a study performed on 
rodents, researchers reported that overfeeding animals led to increased local se-
cretion of angiotensinogen from adipocytes, which in turn resulted in the for-
mation of high amounts of angiotensin II in the local adipose tissue. Further, 
angiotensin II was responsible for the upregulation of adipose tissue growth by 
stimulating prostacyclin release, which recruits preadipocytes and lipogenic en-
zymes. The increased adipose tissue mass and blood pressure of mouse models 
were evident for the activity of angiotensinogen. In addition, studies on obese 
hypertensive human subjects revealed elevated levels of angiotensin II in the 
adipose tissue that may be related to insulin resistance as blockade of RAS had 
beneficial impacts on the development of type 2 diabetes and insulin sensitivity 
[20]. Knowledge of the mechanisms by which adipose-tissue RAS induce insulin 
resistance under pathological metabolic conditions can impact standard treat-
ments. In relation to the PVAT used in this investigation, the characteristic WAT 
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content of rat mesenteric PVAT has been related to a significantly high expres-
sion levels of angiotensin II and its receptors AT1a and AT2 compared to the 
brown periaortic PVAT in healthy conditions [21]. Lu and colleagues [10] have 
also reported a strong expression of angiotensinogen and angiotensin-converting 
enzyme (ACE) mRNA in rat mesenteric PVAT suggesting that white PVAT may 
have a higher sensitivity to angiotensin II. Subsequently, under the influence of 
conditions like obesity and hypertension, white visceral fat surrounding some 
major organs may affect its vascular networks. 
In the present study, levels of PVAT-derived constricting factors may have 
overcome opposite actions of relaxing factors, such as adiponectin and angioten-
sin 1 - 7, in relaxation functional testing with carbachol and SNAP. As was re-
ported in Figure 5, NO levels were higher in PVAT treated with AICAR, with 
the subclavian PVAT levels being significant, suggesting that AMPK expression in 
PVAT is involved in generation of NO. However, functional testing with AICAR 
on pre-contracted rings with and without PVAT showed no relaxation in both 
rings (data not shown). This might be due to factors that could affect AMPK ex-
pression and function such as glucose, fatty acids and amino acids [22]. Moreo-
ver, NO generation by AMPK in the PVAT did not augment relaxation responses 
to carbachol and SNAP. Therefore, preliminary results suggest that carbachol 
and SNAP molecular pathways did not involve the activation of AMPK in NO 
production or subsequent activation of soluble guanylyl cyclase in VSMCs. Ad-
ditionally, PVAT-derived relaxation factor adiponectin hypothesized to activate 
AMPK [8] may not have been secreted during relaxation. In addition, for the 
role of AMPK in endothelium-dependent and -independent relaxation to be 
discerned, further studies investigating the effects of AMPK inhibitors on pre- 
contracted rings during relaxation testing with carbachol and SNAP are warranted. 
Furthermore, investigating adiponectin expression levels in subclavian and iliac 
PVAT may account for the contractile actions of PVAT during relaxation tests. 
Generally, inhibition of angiotensin II may reveal different behavior by the arte-
ries under contraction and relaxation functional testing. 
Certainly, studies have reported the increased infiltration of immune cells into 
WAT under conditions like obesity, hypertension and diabetes, where recruit-
ment rates of monocytes and activation of macrophages are increased, would 
eventually lead to activation of TNFs and interleukins that lead to inflammation 
[23]. Adipocyte hypertrophy also leads to elevated inflammatory signaling path-
ways, such as chemokines, oxidative stress and pro-inflammatory adipokines 
that attracts immune cells to the locally inflamed adipose tissue [2]. In a study 
comparing white PVAT of abdominal aorta to brown PVAT of thoracic aorta, 
mRNA of macrophage proinflammatory chemokines along with their receptors 
were reported to be significantly elevated in abdominal PVAT compared to tho-
racic PVAT under obese conditions in mice. Moreover, abdominal PVAT release 
of monocyte chemoattractant protein-1 (MCP-1) and macrophage recruitment 
were significantly higher than release in thoracic PVAT, with augmented levels 
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seen in both PVATs under the influence of infused angiotensin II in obese mice. 
Incidents of abdominal aortic aneurysm were also measured and were found to 
be more frequent in angiotensin II-infused mice [24]. Another study investigat-
ing the activation and signaling of immune cells in white adipose tissue in hu-
mans, omental adipose tissue in obese individuals suffering from liver lipid ac-
cumulation showed an elevated expression of interleukin-6 mRNA contrary to 
individuals with hyperinsulinemic-euglycemic status with glucose infusion. Ad-
ditionally, high expression of interleukin-6 cytokine correlated positively with 
white mesenteric adipose tissue lipolysis induced by interleukin-6 signaling, 
which ultimately resulted in liver lipid accumulation and insulin resistance [25]. 
White adipose tissue is also related to development of atherosclerosis according 
to this study. It involved the comparison of apolipoprotein E (ApoE)-knockout 
mice with the wild type on high cholesterol diet and normal diet. Experimental 
results show increased levels of atherosclerotic plaques, macrophages and T-lym- 
phocytes in white PVAT of aortic roots of AopE-knockout mice on cholesterol 
diet with increased transcription of interleukin-1β, interleukin-6 and interleu-
kin-1 receptor. Moreover, liver staining of ApoE-knockout mice on cholesterol 
diet revealed high infiltration levels of macrophages and T-lymphocytes; as well 
as high levels of mRNA of interleukin-1 receptor. In ApoE-knockout mice on 
normal diet, white mesenteric adipose tissue showed increased levels of macro-
phages, mRNA of interleukin-6 and interleukin-1; along with high plasma levels 
of TNF-α and interleukin-1β [26]. Therefore, with the growing evidence that 
white PVAT demonstrating increased infiltration of immune cells and cytokines 
in pathological states and the high expression of RAS members and its receptors, 
emphasis is projected towards identifying the molecular mechanisms that con-
trol the level of involvement of PVAT-induced adipokines, cytokines, interleu-
kins and their corresponding enzymes in the aggravation of the pathological 
conditions, which may later prove the importance of PVAT in vascular modula-
tion and the significant potential to be a pharmacological target in the near fu-
ture. 
5. Conclusion 
The results of this investigation demonstrate the pro-contractile effects of sub-
clavian and iliac PVAT under the influence of adrenergic receptor stimulation 
by phenylephrine and noradrenaline, and with relaxant factors carbachol and 
SNAP targeting endothelium-dependent and -independent mechanisms respec-
tively. Histological staining revealed the WAT characteristics of the subclavian 
and iliac PVAT. Moreover, NO generation of PVAT treated with the AMPK ac-
tivator AICAR was higher than untreated PVAT. Effects of AMPK may have 
been overcome by the pro-contractile effects of PVAT; however, to be certain of 
this, inhibitors of angiotensin II, leptin or anti-inflammatories may be used during 
functional testing of the rings. Additionally, measurements of ELISA levels of 
angiotensin II may account for the pro-contractility seen in PVAT. Although 
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rabbits used were in healthy condition and without a sign of obesity, investigat-
ing immune cell activation and migration to PVAT along with expression levels 
of TNF-α, interleukin-1, interleukin-6 and macrophages may reveal obscure re-
sults. It is due to time limitations we were not able to deliver concrete data to 
fully prove our conclusions. Future studies may replicate the data shown using 
rabbit model and compare it to data from mouse model, as PVAT studies in 
rabbits were insufficient at the time this investigation was done. 
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